NASDAQ:CNAT - Conatus Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.2850 -0.10 (-7.22 %)
(As of 12/18/2018 12:18 PM ET)
Previous Close$1.39
Today's Range$1.22 - $1.43
52-Week Range$1.36 - $7.95
Volume816,252 shs
Average Volume1.11 million shs
Market Capitalization$46 million
P/E Ratio-2.11
Dividend YieldN/A

Analyst Ratings

Conatus Pharmaceuticals (NASDAQ:CNAT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Conatus Pharmaceuticals in the last 12 months. Their average twelve-month price target is $11.1150, suggesting that the stock has a possible upside of 764.98%. The high price target for CNAT is $20.00 and the low price target for CNAT is $4.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.803.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.1150$11.7980$12.4983$12.1414
Price Target Upside: 764.98% upside127.76% upside213.24% upside229.93% upside

Conatus Pharmaceuticals (NASDAQ:CNAT) Consensus Price Target History

Price Target History for Conatus Pharmaceuticals (NASDAQ:CNAT)

Conatus Pharmaceuticals (NASDAQ:CNAT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2018SunTrust BanksLower Price TargetBuy$12.00HighView Rating Details
12/6/2018Stifel NicolausDowngradeBuy ➝ Hold$4.00HighView Rating Details
12/6/2018OppenheimerSet Price TargetBuy$14.00 ➝ $10.00HighView Rating Details
11/5/2018HC WainwrightReiterated RatingBuyLowView Rating Details
2/8/2018Roth CapitalInitiated CoverageBuy ➝ Buy$20.00HighView Rating Details
1/24/2018S&P Equity ResearchBoost Price Target$5.02 ➝ $5.69HighView Rating Details
10/6/2017Seaport Global SecuritiesReiterated RatingBuy$16.00N/AView Rating Details
5/15/2017AegisReiterated RatingBuy$11.00N/AView Rating Details
3/15/2017FBR & CoReiterated RatingOutperform$16.00HighView Rating Details
(Data available from 12/18/2016 forward)
This page was last updated on 12/18/2018 by Staff

Featured Article: Liquidity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel